Michael J. Welsh, Director at CANCER GENETICS, INC (CGIX), bought 40 shares at $2.42 ($97) on 2016-03-16, disclosed to the SEC on 2016-03-17.
Open-market purchase of $97 CGIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.